Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
21696 | 409 | 33.0 | 56% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
1 | 4 | ECONOMICS//EDUCATION & EDUCATIONAL RESEARCH//PSYCHOL | 3876184 |
154 | 3 | PSYCHIATRY//ALEXITHYMIA//PSYCHIAT | 62481 |
207 | 2 | PSYCHIATRY//ANTIDEPRESSANTS//DEPRESSION | 21074 |
21696 | 1 | DISCONTINUATION SYNDROME//DISCONTINUATION SYMPTOMS//WITHDRAWAL REACTIONS | 409 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | DISCONTINUATION SYNDROME | authKW | 863032 | 4% | 68% | 17 |
2 | DISCONTINUATION SYMPTOMS | authKW | 457277 | 2% | 88% | 7 |
3 | WITHDRAWAL REACTIONS | authKW | 167978 | 1% | 75% | 3 |
4 | ADRENERGIC CHOLINERGIC BALANCE | authKW | 149315 | 0% | 100% | 2 |
5 | ANTIDEPRESSANT WITHDRAWAL | authKW | 74658 | 0% | 100% | 1 |
6 | BIPOLAR HYPOMANIA | authKW | 74658 | 0% | 100% | 1 |
7 | CBV CHANGES | authKW | 74658 | 0% | 100% | 1 |
8 | DIACYLGLYCEROL KINASE ETA DGKH | authKW | 74658 | 0% | 100% | 1 |
9 | DISCIPLINA FUNDAMENTOS HOMEOPATIA | address | 74658 | 0% | 100% | 1 |
10 | DISCONTINUATION EMERGENT EVENTS | authKW | 74658 | 0% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Psychiatry | 10847 | 58% | 0% | 238 |
2 | Pharmacology & Pharmacy | 1246 | 33% | 0% | 136 |
3 | Neurosciences | 1025 | 30% | 0% | 124 |
4 | Clinical Neurology | 484 | 16% | 0% | 66 |
5 | Psychology, Clinical | 162 | 5% | 0% | 20 |
6 | Behavioral Sciences | 160 | 5% | 0% | 20 |
7 | Psychology | 63 | 3% | 0% | 13 |
8 | Substance Abuse | 57 | 2% | 0% | 8 |
9 | Endocrinology & Metabolism | 53 | 6% | 0% | 23 |
10 | Medicine, General & Internal | 41 | 6% | 0% | 26 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | DISCIPLINA FUNDAMENTOS HOMEOPATIA | 74658 | 0% | 100% | 1 |
2 | DISTURBI AFFETTIVI | 74658 | 0% | 100% | 1 |
3 | HIMOROGI PSYCHIAT | 74658 | 0% | 100% | 1 |
4 | INT CONSORTIUM MOOD DISORDERS | 74658 | 0% | 100% | 1 |
5 | MENTAL EDUC CLIN | 74658 | 0% | 100% | 1 |
6 | PSYCHIAT MENTAL HLTH 116A | 74658 | 0% | 100% | 1 |
7 | REG PHARMACOVIGILANCE CHAMPAGNE ARDENNE | 74658 | 0% | 100% | 1 |
8 | SANTE IN IDUS SOC | 74658 | 0% | 100% | 1 |
9 | SOC EPILEPSY GRP | 74658 | 0% | 100% | 1 |
10 | SYNTHON BV | 74658 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | BIOLOGICAL PSYCHIATRY | 7916 | 8% | 0% | 31 |
2 | ACTIVITAS NERVOSA SUPERIOR | 7781 | 2% | 1% | 10 |
3 | JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY | 6192 | 4% | 1% | 15 |
4 | HOMEOSTASIS IN HEALTH AND DISEASE | 3974 | 1% | 1% | 4 |
5 | JOURNAL OF CLINICAL PSYCHIATRY | 3026 | 4% | 0% | 17 |
6 | PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY | 2971 | 3% | 0% | 14 |
7 | BRAIN RESEARCH REVIEWS | 2851 | 2% | 1% | 7 |
8 | AMERICAN JOURNAL OF PSYCHIATRY | 2740 | 4% | 0% | 18 |
9 | PHARMACOPSYCHIATRIA | 2527 | 0% | 2% | 2 |
10 | JOURNAL OF PSYCHOPHARMACOLOGY | 2076 | 2% | 0% | 8 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | FAVA, GA , GATTI, A , BELAISE, C , GUIDI, J , OFFIDANI, E , (2015) WITHDRAWAL SYMPTOMS AFTER SELECTIVE SEROTONIN REUPTAKE INHIBITOR DISCONTINUATION: A SYSTEMATIC REVIEW.PSYCHOTHERAPY AND PSYCHOSOMATICS. VOL. 84. ISSUE 2. P. 72 -81 | 33 | 61% | 22 |
2 | NARAYAN, V , HADDAD, PM , (2011) ANTIDEPRESSANT DISCONTINUATION MANIC STATES: A CRITICAL REVIEW OF THE LITERATURE AND SUGGESTED DIAGNOSTIC CRITERIA.JOURNAL OF PSYCHOPHARMACOLOGY. VOL. 25. ISSUE 3. P. 306 -313 | 23 | 77% | 6 |
3 | HADDAD, PM , (2001) ANTIDEPRESSANT DISCONTINUATION SYNDROMES - CLINICAL RELEVANCE, PREVENTION AND MANAGEMENT.DRUG SAFETY. VOL. 24. ISSUE 3. P. 183 -197 | 32 | 64% | 94 |
4 | BOGETTO, F , BELLINO, S , REVELLO, RB , PATRIA, L , (2002) DISCONTINUATION SYNDROME IN DYSTHYMIC PATIENTS TREATED WITH SELECTIVE SEROTONIN REUPTAKE INHIBITORS - A CLINICAL INVESTIGATION.CNS DRUGS. VOL. 16. ISSUE 4. P. 273-283 | 24 | 89% | 40 |
5 | TAMAM, L , OZPOYRAZ, N , (2002) SELECTIVE SEROTONIN REUPTAKE INHIBITOR DISCONTINUATION SYNDROME: A REVIEW.ADVANCES IN THERAPY. VOL. 19. ISSUE 1. P. 17 -26 | 20 | 87% | 32 |
6 | LEJOYEUX, M , ADES, J , MOURAD, I , SOLOMON, J , DILSAVER, S , (1996) ANTIDEPRESSANT WITHDRAWAL SYNDROME - RECOGNITION, PREVENTION AND MANAGEMENT.CNS DRUGS. VOL. 5. ISSUE 4. P. 278-292 | 27 | 75% | 36 |
7 | RUSCONI, AC , CARLONE, C , MUSCILLO, M , DE'FORNARI, MAC , PODDA, L , PICCIONE, M , (2009) SSRI DISCONTINUATION SYNDROME: INCIDENCE AND DIFFERENCES ON THREE GROUPS OF PATIENTS TREATED WITH PAROXETINE.RIVISTA DI PSICHIATRIA. VOL. 44. ISSUE 3. P. 169 -175 | 15 | 88% | 2 |
8 | DEGNER, D , RUTHER, E , GROHMANN, R , (2009) ELECTRIC SHOCK-LIKE SENSATIONS (PARESTHESIA) ON VENLAFAXIN DISCONTINUATION.PSYCHOPHARMAKOTHERAPIE. VOL. 16. ISSUE 4. P. 170-173 | 13 | 100% | 0 |
9 | TAMAM, L , OZPOYRAZ, N , (2003) DISCONTINUATION SYMPTOMS ASSOCIATED WITH NEFAZODONE.JOURNAL OF PSYCHOPHARMACOLOGY. VOL. 17. ISSUE 4. P. 447-450 | 16 | 94% | 0 |
10 | MONTGOMERY, SA , FAVA, M , PADMANABHAN, SK , GUICO-PABIA, CJ , TOURIAN, KA , (2009) DISCONTINUATION SYMPTOMS AND TAPER/POSTSTUDY-EMERGENT ADVERSE EVENTS WITH DESVENLAFAXINE TREATMENT FOR MAJOR DEPRESSIVE DISORDER.INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY. VOL. 24. ISSUE 6. P. 296-305 | 20 | 59% | 6 |
Classes with closest relation at Level 1 |